Morris, Erick J.
Merck & Co., Inc., Rahway, NJ, USA (United States)
2 papers on CoChatORCID 0000-0002-3566-5630
Most cited papers
- Verified
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors.
Morris, E. J., Jha, S., Restaino, C. R., Dayananth, P., Zhu, H., Cooper, A., Carr, D., Deng, Y., Jin, W., Black, S., et al. (2013) · Cancer Discovery
Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling
Cited by 676
- Verified
Retinoblastoma protein partners
Morris, E. J., & Dyson, N. J. (2001) · Advances in Cancer Research
Cancer-related Molecular PathwaysRetinal Development and Disorders
Cited by 349
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free